CellWell record HH-479763
A One-Year Retrospective Observational Study Reveals the Transient Nature of Pemafibrate-Induced LDL-C Elevation: Implications Beyond the PROMINENT Trial
Chie Iitake; Kazuhiro Iitake
2026
In plain language
In 110 patients taking pemafibrate, LDL-C rose modestly at three months, then returned to baseline by twelve months while triglycerides fell markedly, with low baseline LDL-C the strongest predictor of the rise.
- Evidence
- Emerging
- Design
- Observational study
Cite this record: https://thecellwell.org/studies/HH-479763
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.